Views | |
---|---|
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema | 251 |
March 2025 | April 2025 | May 2025 | June 2025 | July 2025 | August 2025 | September 2025 | |
---|---|---|---|---|---|---|---|
An open-label study to evaluate the long-term safety and efficacy of lanadelumab for prevention of attacks in hereditary angioedema | 5 | 2 | 14 | 2 | 2 | 4 | 0 |
Views | |
---|---|
s13601-017-0172-9.pdf | 234 |